Why precision medicine won’t transform healthcare – but governance could

healthcare

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.Author: Emma Charlton, Senior Writer, Formative Content


  • A review by more than 40 experts recently found that precision medicine’s key barriers exist in policy and governance, not science and technology.
  • Unlocking data, prioritizing inclusivity and rethinking pricing models are key to maximizing precision medicine’s full potential.

Could precision medicine see a resurgence in the post-COVID era? Not without fixing longstanding policy and governance challenges like cross-border data access, ethical technology development, genomic data policies and viability of diagnostics development.

That was the message from more than 40 global experts from across the healthcare ecosystem recently. They took a hard look at the barriers standing in the way of precision medicine approaches over the last 12 months part of the World Economic Forum’s Global Fourth Industrial Revolution Councils. The barriers they identified were not in science and technology but in policy and governance, ranging from laws to standards that set the “rules of the road” for corporations, governments and international organizations.

Health and healthcare

How is the World Economic Forum bringing data-driven healthcare to life?

The application of “precision medicine” to save and improve lives relies on good-quality, easily-accessible data on everything from our DNA to lifestyle and environmental factors. The opposite to a one-size-fits-all healthcare system, it has vast, untapped potential to transform the treatment and prediction of rare diseases—and disease in general.

But there is no global governance framework for such data and no common data portal. This is a problem that contributes to the premature deaths of hundreds of millions of rare-disease patients worldwide.

The World Economic Forum’s Breaking Barriers to Health Data Governance initiative is focused on creating, testing and growing a framework to support effective and responsible access – across borders – to sensitive health data for the treatment and diagnosis of rare diseases.

The data will be shared via a “federated data system”: a decentralized approach that allows different institutions to access each other’s data without that data ever leaving the organization it originated from. This is done via an application programming interface and strikes a balance between simply pooling data (posing security concerns) and limiting access completely.

The project is a collaboration between entities in the UK (Genomics England), Australia (Australian Genomics Health Alliance), Canada (Genomics4RD), and the US (Intermountain Healthcare).

As a result of their review, these expert Council Members had some tough words for the healthcare systems and the policymakers who need to adapt – and quickly – to accelerate healthcare systems’ movement toward precision medicine and better address a range of health issues from cancer to the current COVID-19 crisis.

“Unfortunately, more than half of the world’s population still has no access to precision medicine and is unable to reap the benefits,” wrote the Council in the Precision Medicine Vision Statement, released this week. “We must be ever vigilant about increasing the capabilities of many countries and populations to join this global movement towards more personalized and targeted ways of screening, preventing, diagnosing, treating and curing patients with disease.”

1. Unlock the data

The lack of data interoperability is a key barrier to achieving precision medicine’s potential. Data interoperability is the capability of different programs to exchange data via a common set of formats. Without international data standards on genomic data, for example, we won’t be able to integrate data on genetic markers (specific sequences in our genetic blueprint that make us unique) into patient records so researchers can understand why one patient or population may be particularly susceptible to COVID-19. The lack of data interoperability is currently standing in the way of enabling large-scale data analytics to track and understand the spread of COVID-19 and tailoring patient treatments to fight the pandemic.

Such genomic data standards are being developed to help with interoperability, along with ways of federating data to ask questions of patient records across different countries. Still, the deployment of these standards needs to be greatly accelerated. For example, 475 million people are affected by rare disease worldwide, and only 5% of people with a rare disease receive treatment. Accelerating our ability to share data globally could provide benefits to diagnosis, disease management and treatment, clinical trials and personal well-being.

2. Ethical inclusion of vulnerable populations

COVID-19 is highlighting the need for ethical guidelines to guide inclusive technology development and deployment. The World Health Organization makes it clear that even in public health emergencies, research like clinical trials for new drugs to treat COVID-19 should be done in a way that protects but does not exclude vulnerable groups like pregnant women, minorities, and children.

We know that research studies often do not engage under-represented populations and if they do, often the results are not broken down by gender or ethnicity. For instance, we have some evidence that women recover from COVID-19 at a higher rate than men, but if we lump together all genders in when reporting research results of new treatments, we may be unable to understand why. If we do not prioritize including minorities (who are disproportionately impacted by COVID-19) in studies, we will not know which treatments work best for these vulnerable populations.

Furthermore, representativeness and inclusivity in medical research must be addressed for precision medicine advances to be applicable to populations outside of Europe and North America. The Council’s Members worry, rightly so, that many precision medicine treatments and diagnostics will not work very well when applied in other populations around the world who are in desperate need of high quality, value-based healthcare.

healthcare

What is the World Economic Forum doing about healthcare value and spending?

Each year, $3.2 trillion is spent on global healthcare making little or no impact on good health outcomes.

To address this issue, the World Economic Forum created the Global Coalition for Value in Healthcare to accelerate value-based health systems transformation.

This council partners with governments, leading companies, academia, and experts from around the world to co-design and pilot innovative new approaches to person-centered healthcare.

3. Pay a fair price for diagnostics

The diagnostics space has been chronically underfunded, subject to regulatory confusion, and boom-and-bust cycles. The current business models for diagnostics development do not support sustainable investment in science and technology or the capacity for building infrastructure needed to scale, particularly in emerging economies. This uncertainty plagues companies developing genetic tests to diagnose people with conditions such as kidney disease that can then be targeted by precision treatments. For this reason, diagnostics drive 70% of healthcare decisions, but only account for 2% of healthcare spending in the United States.

We need a shift in the value proposition and pricing models that accurately reflect the role of diagnostics in the entire healthcare journey. Instead of viewing diagnostics as a small step at the beginning of a healthcare journey, we need to consider the true value of knowing up front which treatment will be right for a specific person. Right now, without reimbursing the diagnostic test for what it is – a “sign post” that guides the next steps of prevention or treatment and cure – we will continue to suffer from a lack of cutting edge and widely available diagnostic tools.

“With guidance in place, the global community can continue to come together to build new solutions and reset how we look at healthcare from a precision perspective.”

—Genya Dana

The Global Precision Medicine Council’s Vision Statement for Precision Medicine provides case studies to illustrate how to bridge these key governance gaps. The document includes models that offer guidance in a variety of areas including: building trust and engagement for direct-to-consumer genetic testing, increasing access to precision therapeutics in fast track situations, and structuring regulatory systems to innovate around genomic data privacy and ownership.

The Council’s work to date is a first step towards developing the robust international collaborative environment needed to understand the many challenges that exist and to test solutions that bridge policy and governance gaps. These same governance gaps also stand in the way of treating COVID-19 in an ethical, timely, and coordinated way. With guidance in place, the global community can continue to come together to build new solutions and reset how we look at healthcare from a precision perspective.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Record-breaking heatwaves killed about 1,500 people in France

EU and US close to an agreement on data sharing amid European citizens’ concerns

Technology companies have power. They must assume responsibility

‘Disaster resilient’ farming reduces agriculture risks, yields economic gains, says new UN agriculture agency report

Will Cameron succeed in keeping UK inside the EU and reverse the present economic downturn?

Without tackling ‘gross inequalities’ major issues will go unsolved, warns UN rights chief Bachelet

Our Amazon is disappearing in ashes

The “Legend of the Sun” wishes you Happy Chinese New Year 2015 from Brussels

Health Systems and Society: ways to reinforce the human power during the pandemic

Italian elections: a long political limbo is ahead

Eurozone: Subdued inflation can lead to more recession

How can education empower youth to become tomorrow’s leaders

‘Millions facing starvation’ – Global political and business leaders on the economic impact of COVID-19

Women’s rights in Asia – how far have we come?

European Commission and International Monetary Fund strengthen cooperation to support sustainable development

Negotiations on Investment Facilitation at the WTO gain support at Davos

China-EU Relations: Broader, Higher and Stronger

Tuesday’s Daily Brief: hate speech, dementia, Libya and Yemen, human rights in Brazil and Lebanon

‘The best-selling brand today is fear’: UN chief highlights urgent need to address global ‘deficit of trust’

Whale populations are slowly recovering – this is why

Schengen is losing ground fast revealing Europe’s clear inability to deal with migration crisis

EU-China trade: closer ties as US-China trade battle brews

UN chief urges ‘active, substantive and meaningful participation’ on International Day of Democracy

Eurozone guarantees all banks with…taxpayers’ money

Towards the Rise of the United States of the Atlantic?

Universal Health Care: can it exist only in utopic society?

Three myths keeping government procurement stuck in the past

Vital food crops destroyed in Syria amid upsurge in fighting across Idlib, Hama

In Bangladesh, COVID-19 threatens to cause a humanitarian crisis

Human rights breaches in Iran, Egypt and Tanzania

What is digital equality? An interview with Nanjira Sambuli

Spanish vote – bad luck for Greece: Does Iphigenia need to be sacrificed for favourable winds to blow in Eurozone?

Bank resolutions to remain a politically influenced affair

A quarter of Pacific islanders live below ‘basic needs poverty lines’, top UN development forum hears

How the future of computing can make or break the AI revolution

Parliament makes EU electricity market cleaner and more consumer-friendly

European Court rules that ECB’s OMT program of 2012 is OK; not a word from Germany about returning the Greek 2010 courtesy

Venezuela: European Parliament calls for additional sanctions

Green Deal: measures to step up the fight against global deforestation

Mergers: Commission clears acquisition of joint control over INWIT by Telecom Italia and Vodafone, subject to conditions

Data Protection Regulation one year on: 73% of Europeans have heard of at least one of their rights

The EU slowly exits from “Excessive Deficit Procedure” and hopefully from ‘Excessive Austerity Procedure’ too

Libya: ‘Substantial civilian casualties’ in Derna, UN humanitarian chief ‘deeply concerned’

State aid: France to recover €8.5 million of illegal aid to Ryanair at Montpellier airport

US, Russia oblige each other in Syria and Ukraine selling off allies

‘Once lost, hearing doesn’t come back,’ World Health Organization warns on World Hearing Day

Why do medical students need to emigrate to become doctors in 2017?

Coronavirus in Brazil: mental health in tragedy

Turn toxic e-waste into a source of ‘decent work’, UN labour agency urges

LIFE Programme: Member States to benefit from quarter of a billion euros of investments in environment, nature and climate action

The vehicles of our future

State aid: Commission approves €840 million German guarantee scheme to protect consumers and support the travel industry in the context of the coronavirus outbreak

Eight years in, Syria still embroiled in conflict ‘that no longer sparks outrage’, Security Council hears

MEPs push for high ambitions at the COP25 in Madrid

These clothes were designed by artificial intelligence

Germany readies to pay for the Brexit gap in EU finance

Parliament boosts consumer rights online and offline

Media Advisory : Coronavirus COVID-19 – measures introduced by the European Parliament

Brazil’s hopeless future of science

How AI is bringing the ‘dark matter of nutrition’ to light, unlocking the power of plants

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s